Washington, DC-(Effingham Radio)- The three biggest pharmacy benefit managers are being accused of artificially inflating insulin prices.The FCC says CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx created a system that puts importance on high rebates from drug manufacturers, leading to high list prices for insulin. The companies excluded available insulin products with lower prices that would have been more affordable for patients in favor of…
Read More…
FTC Takes Action Against Pharmacies Inflating Insulin Prices
